Search Results - "Quiles, N"

ASC‐1 Is a Cell Cycle Regulator Associated with Severe and Mild Forms of Myopathy by Villar‐Quiles, Rocío N., Catervi, Fabio, Cabet, Eva, Juntas‐Morales, Raul, Genetti, Casie A., Gidaro, Teresa, Koparir, Asuman, Yüksel, Adnan, Coppens, Sandra, Deconinck, Nicolas, Pierce‐Hoffman, Emma, Lornage, Xavière, Durigneux, Julien, Laporte, Jocelyn, Rendu, John, Romero, Norma B., Beggs, Alan H., Servais, Laurent, Cossée, Mireille, Olivé, Montse, Böhm, Johann, Duband‐Goulet, Isabelle, Ferreiro, Ana

“…Objective Recently, the ASC‐1 complex has been identified as a mechanistic link between amyotrophic lateral sclerosis and spinal muscular atrophy (SMA), and 3…”
Get full text

Aprémilast by Quiles Tsimaratos, N.

Get full text

Macrophage activation syndrome associated with BRAF and MEK inhibitors during adjuvant treatment of melanoma by Demarez, B., Eté, M., David, L., Quiles, N., Archier, E.

Get full text

Perception of mind and dehumanization: Human, animal, or machine? by Morera, María D., Quiles, María N., Correa, Ana D., Delgado, Naira, Leyens, Jacques‐Philippe

“…Dehumanization is reached through several approaches, including the attribute‐based model of mind perception and the metaphor‐based model of dehumanization. We…”
Get full text

Validity and Reliability of the Exercise Vital Sign Questionnaire in an Ethnically Diverse Group: A Pilot Study by Quiles, Norberto N., McCullough, Aston K., Piao, Lin

“…The purpose of this study was to determine the validity and reliability of the Exercise Vital Sign (EVS) questionnaire in an ethnically diverse sample…”
Get full text

Janus kinase inhibitors for the treatment of atopic dermatitis: Real-life data on efficacy and safety in light of the Pharmacovigilance Risk Assessment Committee recommended measures by Reguiai, Z, Becherel, P A, Fougerousse, A C, Chaby, G, Perrot, J L, Begon, E, Jacobzone-Lévêque, C, Boulard, C, Badaoui, A, Poreaux, C, David, L, Quiles-Tsimaratos, N, Lons-Danic, D, Fite, C, Liegeon, A-L, Patchinsky, A, Parier, J, Garcia, C, Estève, E, Mohty, R, Mery-Bossard, L, Maccari, F

Get full text

Observational study on the therapeutic management and economic burden of adult patients with moderate to severe plaque psoriasis in France – the POP study by Villani, A. P., Quiles Tsimaratos, N., Crochard, A., Gherardi, A., Panes, A., Schmidt, A., Hueber Kollen, M., Borget, I.

“…Background: Data on the therapeutic management and healthcare cost of moderate to severe psoriasis in France are scarce.Objective: To assess the therapeutic…”
Get full text

Biological treatments for paediatric psoriasis : a retrospective observational study on biological drug survival in daily practice in childhood psoriasis by Phan, C., Beauchet, A., Burztejn, A.‐C., Severino‐Freire, M., Barbarot, S., Girard, C., Lasek, A., Reguiai, Z., Hadj‐Rabia, S., Abasq, C., Brenaut, E., Droitcourt, C., Perrussel, M., Mallet, S., Phan, A., Lacour, J.‐P., Khemis, A., Bourrat, E., Chaby, G., Deborde, R., Plantin, P., Maruani, A., Piram, M., Maccari, F., Fougerousse, A.‐C., Kupfer‐Bessaguet, I., Balguérie, X., Barthelemy, H., Martin, L., Quiles‐Tsimaratos, N., Mery‐Brossard, L., Pallure, V., Lons‐Danic, D., Bouilly‐Auvray, D., Beylot‐Barry, M., Puzenat, E., Aubin, F., Mahé, E.

“…Background Three biotherapies – etanercept, adalimumab and ustekinumab – are licensed in childhood psoriasis. The few data available on their efficacy and…”
Get full text

Tattoo complications in treated and non‐treated psoriatic patients by Grodner, C., Beauchet, A., Fougerousse, A.‐C., Quiles‐Tsimaratos, N., Perrot, J.‐L., Barthelemy, H., Parier, J., Maccari, F., Beneton, N., Bouilly‐Auvray, D., Ruer‐Mulard, M., Boulard, C., Jacobzone, C., Thomas‐Beaulieu, D., Pourchot, D., Méry‐Bossard, L., Chaby, G., Girard, C., Duval‐Modeste, A.‐B., Vermersch‐Langlin, A., Delaunay, J., Marc, S., Kemula, M., Steff, M., Bilan, P., Liégeon, A.‐L., Aubert, H., Solyga, B., Kluger, N., Mahé, E.

“…Background Tattooing is a widespread phenomenon, with an estimated prevalence of 10–30% in Western populations. For psoriasis patients, current recommendations…”
Get full text

Squamous cell carcinoma over pilonidal chronic disease. A new therapeutic approach by Mayol Oltra, A., Boldó Roda, E., Lozoya Albacar, R., Morillo Macias, V., Nobleja Quiles, N.

“…•Squamous cell carcinoma can appear in chronic pilonidal disease.•En bloc surgery is the main treatment.•Intraoperative radiotherapy could decrease the…”
Get full text

Tattooing and psoriasis: dermatologists’ knowledge, attitudes and practices. An international study by Grodner, C., Kluger, N., Fougerousse, A.‐C., Cinotti, E., Lacarrubba, F., Quiles‐Tsimaratos, N., Mahé, E.

Get full text

Analysis of the Relationship between the Month of Birth and Risk of Multiple Sclerosis in a Spanish Population by Villar-Quiles, Rocío N, Matías-Guiu, Jordi A, Ortega, Gloria, González-Suárez, Inés, Oreja-Guevara, Celia, Matías-Guiu, Jorge

“…Some studies have suggested an association between the month of birth and risk of multiple sclerosis (MS), related to environmental factors, mainly sun…”
Get more information

Factors that may influence the choice for initiating apremilast or methotrexate treatment for psoriasis in real‐world clinical setting by Fougerousse, A.‐C., Maccari, F., Beauchet, A., Parier, J., Boulard, C., Becherel, P.‐A., Quiles‐Tsimaratos, N., Le Guyadec, T., Thomas‐Beaulieu, D., Halioua, B., Begon, E., Bastien, M., Perrot, J.‐L., Pallure, V., Bilan, P., Steff, M., Pfister, P., Vermersch‐Langlin, A., Boyé, T., Mery‐Bossard, L., Maillard, H., Kemula, M., Girard, C., Poiraud, C., Monfort, J.‐B., Kupfer‐Bessaguet, I., Perrussel, M., Lons‐Danic, D., Sultan, N., Lorier, E., Zeitoun, M., Wagner, L., Gabison, G., Mahé, E.

Get full text

Evaluation of risk factors for body weight increment in psoriatic patients on infliximab: a multicentre, cross-sectional study by Mahé, E., Reguiai, Z., Barthelemy, H., Quiles-Tsimaratos, N., Chaby, G., Girard, C., Estève, E., Maccari, F., Descamps, V., Schmutz, J.-L., Begon, E., Bravard, P., Maillard, H., Boyé, T., Beauchet, A., Sigal, M.-L.

“…Background  A significant weight gain has been reported in patients with psoriasis treated with anti‐tumour necrosis factor‐alpha agents. Among these patients,…”
Get full text

Characteristics of patients with plaque psoriasis who have discordance between Psoriasis Area Severity Index and dermatology life quality index scores by Amy de la Breteque, M., Beauchet, A., Quiles‐Tsimaratos, N., Estève, E., Le Guyadec, T., Ruer‐Mulard, M., Maccari, F., Reguiai, Z., Girard, C., Bastien, M., Avenel‐Audran, M., Pauwels, C., Bouilly‐Auvray, D., Sigal, M.‐L., Mahé, E.

Get full text

The effects of exercise on lipid profile and blood glucose levels in people living with HIV: A systematic review of randomized controlled trials by Quiles, Norberto N., Piao, Lin, Ortiz, Alexis

“…Exercise is commonly prescribed to improve lipid profile and glucose levels in people living with HIV (PLWH). This systematic review was performed in order to…”
Get full text

Exercise as an adjunct to nicotine gum in treating tobacco dependence among women by Kinnunen, Taru, Leeman, Robert F., Korhonen, Tellervo, Quiles, Zandra N., Terwal, Donna M., Garvey, Arthur J., Hartley, L. Howard

“…This was the first randomized, controlled smoking cessation trial assessing the efficacy of an exercise intervention as an adjunct to nicotine gum therapy in…”
Get full text

Criterion Validity and Reliability of 2 Brief Physical Activity Questionnaires in Ethnically Diverse Adults by Quiles, Norberto N, Uher, David, Balachandran, Anoop, Ortiz, Alexis, Garber, Carol

“…The study compares moderate- to vigorous-intensity physical activity (MVPA) as evaluated by the Exercise Vital Signs (EVS) and Physical Activity Vital Signs…”
Get more information

Cutaneous adverse events of telaprevir/peginterferon/ribavirin therapy for chronic hepatitis C: A multicenter prospective cohort study by Lorcy, S, Gaudy-Marqueste, C, Botta, D, Portal, I, Quiles, N, Oulies, V, Mancini, J, Grob, J-J, Richard, M-A

“…Telaprevir, sale of which was suspended, has been approved in combination with pegylated interferon and ribavirin (triple therapy) in the treatment of chronic…”
Get full text

The clinical, histologic, and genotypic spectrum of SEPN1-related myopathy: A case series by Villar-Quiles, Rocio N., von der Hagen, Maja, Métay, Corinne, Gonzalez, Victoria, Donkervoort, Sandra, Bertini, Enrico, Castiglioni, Claudia, Chaigne, Denys, Colomer, Jaume, Cuadrado, Maria Luz, de Visser, Marianne, Desguerre, Isabelle, Eymard, Bruno, Goemans, Nathalie, Kaindl, Angela, Lagrue, Emmanuelle, Lütschg, Jürg, Malfatti, Edoardo, Mayer, Michèle, Merlini, Luciano, Orlikowski, David, Reuner, Ulrike, Salih, Mustafa A., Schlotter-Weigel, Beate, Stoetter, Mechthild, Straub, Volker, Topaloglu, Haluk, Urtizberea, J. Andoni, van der Kooi, Anneke, Wilichowski, Ekkehard, Romero, Norma B., Fardeau, Michel, Bönnemann, Carsten G., Estournet, Brigitte, Richard, Pascale, Quijano-Roy, Susana, Schara, Ulrike, Ferreiro, Ana

“…To clarify the prevalence, long-term natural history, and severity determinants of -related myopathy (SEPN1-RM), we analyzed a large international case series…”
Get full text